Page last updated: 2024-08-23

paroxetine and Genital Neoplasms, Female

paroxetine has been researched along with Genital Neoplasms, Female in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aloisi, A; Angioli, R; Capriglione, S; Lopez, S; Luvero, D; Montera, R; Plotti, F; Scaletta, G; Serra, GB	1

Trials

1 trial(s) available for paroxetine and Genital Neoplasms, Female

Article	Year
Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial. Gynecologic oncology, 2016, Volume: 143, Issue:3 Topics: Adult; Aged; Double-Blind Method; Female; Genital Neoplasms, Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Survivors; Treatment Outcome	2016

Article

Year

Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial.

Gynecologic oncology, 2016, Volume: 143, Issue:3

Topics: Adult; Aged; Double-Blind Method; Female; Genital Neoplasms, Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Survivors; Treatment Outcome

2016